Safe and Efficacious Allogeneic Bone Marrow Transplantation for Nonmalignant Disorders Using Partial T Cell Depletion and No Posttransplantation Graft-Versus-Host-Disease Prophylaxis

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 3, 2007, Pages 329-338

  Elhasid, Ronit ^a,f   Arush, Myriam Ben ^a,f   Zaidman, Irena ^a   Leiba, Ronit ^c   Barak, Ayelet Ben ^a   Postovsky, Sergey ^a   Haddad, Nuhad ^b   Katz, Tami ^b   Pollack, Shimon ^b,f   Sami, Ivanka ^b   Gidoni, Osnat ^b   Rubin, Dina ^b   Mandel, Hanna ^d,f   Attias, Dina ^e,f   Reisner, Yair ^g   Etzioni, Amos ^a,f   Rowe, Jacob M ^b,f  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b Department of Hematology and Bone Marrow Transplantation ^*  (Israel)

^c Quality Improvement Unit   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e BNAI ZION MEDICAL CENTER   (Israel)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CD34 cells; Matched related donor; Nonmalignant disease; Peripheral stem cell transplantation; T cell depletion

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIURETIC AGENT; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; CAPILLARY LEAK SYNDROME; CD34 SELECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; COMPARTMENT SYNDROME; COOMBS TEST; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEBRILE NEUTROPENIA; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HLA MATCHING; HUMAN; HURLER SYNDROME; IMMUNOMAGNETIC SEPARATION; INFANT; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; OSTEOPOROSIS; PARACENTESIS; POLYMERASE CHAIN REACTION; PUVA; REINFECTION; SANFILIPPO SYNDROME; SURVIVAL TIME; T CELL DEPLETION; THALASSEMIA MAJOR; VEIN OCCLUSION; VIRUS REACTIVATION; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNE SYSTEM; INFANT; LYMPHOCYTE DEPLETION; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33847011704     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.10.028     Document Type: Article

References (35)

1. Jacobsohn D.A., Duerst R., Tse W., et al. Reduced-intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 364 (2004) 156-162
2. Devetten M.P., and Vose J.M. Graft-versus-host disease: how to translate new insights into new therapeutic strategies. Biol Blood Marrow Transplant 10 (2004) 815-825
3. Patterson J., Prentice H.G., Brenner M.K., et al. Graft rejection following HLA-matched T-lymphocyte-depleted bone marrow transplantation. Br J Haematol 63 (1986) 221-230
4. Daley J.P., Rozans M.K., Smith B.R., et al. Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood 70 (1987) 960-964
5. Shapiro R.S., McClain K., Frizzera G., et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders following bone marrow transplantation. Blood 71 (1988) 1234-1243
6. Bhatia S., Ramsay N.K., Steinbuch M., et al. Malignant neoplasms following bone marrow transplantation. Blood 87 (1996) 3633-3639
7. Atkinson K., Farrell H., Cooley M., et al. Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease. Bone Marrow Transplant 2 (1987) 51-57
8. Kernan N.A., Collins N.H., Juliano L., et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-versus-host disease. Blood 68 (1986) 770-773
9. Soiffer R.J., and Martin P. T cell depletion of allogeneic hematopoietic stem cell grafts. In: Atkinson K., Champlin R., Ritz J., et al. (Eds). Clinical Bone Marrow and Blood Stem Cell Transplantation (2004), Cambridge University Press, Cambridge, UK 416-425
10. Haddad N., Katz T., Fineman R., et al. Allogeneic BMT for CML using partial T cell depletion and no post-transplant GVHD prophylaxis, an effective regimen with reduced toxicity: 31 patients treated in a single institution. Blood 102 (2003) 2625a (abstr.)
11. Bachar-Lustig E., Rachamim N., Li H.W., et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1 (1995) 1268-1273
12. Baronciani D., Galimberti M., Lucarelli G., et al. Bone marrow transplantation in class 1 thalassemia patients. Bone Marrow Transplant 12 (1993) S56-S58
13. Elhasid R., Hofbauer L.C., Ish-Shalom S., et al. Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. Am J Hematol 72 (2003) 34-37
14. Schmidt J., Fleissner S., Heimann-Weitschat I., et al. Effect of corticosteroids, cyclosporine A, and methotrexate on cytokine release from monocytes and T cell subsets. Immunopharmacology 27 (1994) 173-179
15. Krivoy N., Hoffer E., Tabak A., et al. Therapeutic monitoring of busulphan in pediatric bone marrow transplantation. Pediatr Hematol Oncol 19 (2002) 31-37
16. Atkinson K., Horowitz M.M., Gale R.P., et al., Committee of the International Bone Marrow Transplant Registry. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 4 (1989) 247-254
17. Sullivan K.M., Deeg H.J., Sanders J., et al. Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 67 (1986) 1172-1175
18. + progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant 33 (2004) 25-32
19. Reisner Y., and Martelli M.F. Stem cell escalation enables HLA-disparate haematopoietic transplants in leukemia patients. Immunol Today 20 (1999) 343-347
20. + stem cells: a new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 12 (2000) 536-541
21. Couriel D., Caldera H., Champlin R., et al. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 101 (2004) 1936-1946
22. Lee S.J., Vogelsang G., Gilman A., et al. A survey of diagnosis, management and grading of chronic GVHD. Biol Blood Marrow Transplant 8 (2002) 32-39
23. Gustafsson Jernberg A., Remberger M., Ringden O., et al. Graft-versus-leukemia effect in children: chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplant 31 (2003) 175-181
24. Eapen M., Horowitz M.M., Klein J.P., et al. Higher mortality after allogeneic peripheral blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 22 (2004) 4872-4880
25. Peters C., Shapiro E.G., Anderson J., et al. Hurler syndrome: II. Outcome of HLA genotypically identical sibling and HLA haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91 (1998) 2601-2608
26. Gaziev D., Polchi P., Galimberti M., et al. Graft-versus-host disease after bone marrow transplantation in thalassemia: an analysis of incidence and risk factors. Transplantation 63 (1997) 854-860
27. + selected allogeneic hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 11 (2005) 609-618
28. Erer B., Polchi P., Lucarelli G., et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 18 (1996) 157-162
29. Peters C., Charnas L.R., Tan Y., et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104 (2004) 881-888
30. Couriel D., Canosa J., Engler H., et al. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T cell-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 18 (1996) 347-353
31. Ouachee-Chardin M., Elie C., de Saint Basile G., et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 117 (2006) 743-750
32. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
33. Dubovsky J., Daxberger H., Fritsch G., et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 3 (1999) 2059-2069
34. Andreani M., Manna M., and Lucarelli G. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 87 (1996) 3494-3499
35. Lucarelli G., Clift R.A., Galimberti M., et al. Bone marrow transplantation in adult thalassemic patients. Blood 93 (1999) 1164-1167